A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Journal of Experimental and Clinical Medicine
Volume:39 Issue:2
A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS

A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS

Authors : Dursun Fırat ERGÜL, Maruf BORAN

Pages : 563-565

View : 64 | Download : 8

Publication Date : 2022-03-18

Article Type : Other Papers

Abstract :The recent global outbreak of coronavirus disease-19, also known as COVID-19, has infected more than 142 million people worldwide, causing more than 3 million deaths. It has been shown that up to 40% of hospitalized COVID-19 patients may develop ARDS. Although not proven, anti-inflammatory and anti-cytokine treatments are recommended to suppress the cytokine storm that develops in the early stages of the disease. In this case report, a case of pulmonary aspergillus developed as a complication of treatment for ARDS caused by covid 19 in a 50-year-old male patient will be presented in the light of current literature.
Keywords : covid 19, ARDS, Pulmuner Aspergilloz Basarılı Weaning, Steroid Tedavisi

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.